450 related articles for article (PubMed ID: 25791526)
21. Targeting formyl peptide receptor 1 with anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndrome.
Yang SC; Wang YH; Ho CM; Tsai YF; Sung PJ; Lin TE; Hwang TL
Br J Pharmacol; 2023 Aug; 180(16):2120-2139. PubMed ID: 36929355
[TBL] [Abstract][Full Text] [Related]
22. Propofol inhibits endogenous formyl peptide-induced neutrophil activation and alleviates lung injury.
Chen CY; Tsai YF; Huang WJ; Chang SH; Hwang TL
Free Radic Biol Med; 2018 Dec; 129():372-382. PubMed ID: 30312762
[TBL] [Abstract][Full Text] [Related]
23. Bioactive secondary metabolites of a marine Bacillus sp. inhibit superoxide generation and elastase release in human neutrophils by blocking formyl peptide receptor 1.
Yang SC; Lin CF; Chang WY; Kuo J; Huang YT; Chung PJ; Hwang TL
Molecules; 2013 Jun; 18(6):6455-68. PubMed ID: 23736784
[TBL] [Abstract][Full Text] [Related]
24. Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1.
Lammers KM; Chieppa M; Liu L; Liu S; Omatsu T; Janka-Junttila M; Casolaro V; Reinecker HC; Parent CA; Fasano A
PLoS One; 2015; 10(9):e0138338. PubMed ID: 26378785
[TBL] [Abstract][Full Text] [Related]
25. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.
Forsman H; Winther M; Gabl M; Skovbakke SL; Boulay F; Rabiet MJ; Dahlgren C
Biochim Biophys Acta; 2015 Jan; 1853(1):192-200. PubMed ID: 25447672
[TBL] [Abstract][Full Text] [Related]
26. TLT2 potentiates neutrophil antibacterial activity and chemotaxis in response to G protein-coupled receptor-mediated signaling.
Halpert MM; Thomas KA; King RG; Justement LB
J Immunol; 2011 Sep; 187(5):2346-55. PubMed ID: 21804015
[TBL] [Abstract][Full Text] [Related]
27. A Novel Modality for Functional Imaging in Acute Intervertebral Disk Herniation via Tracking Leukocyte Infiltration.
Xiao L; Ding M; Zhang Y; Chordia M; Pan D; Shimer A; Shen F; Glover D; Jin L; Li X
Mol Imaging Biol; 2017 Oct; 19(5):703-713. PubMed ID: 28050750
[TBL] [Abstract][Full Text] [Related]
28. Formylated MHC Class Ib Binding Peptides Activate Both Human and Mouse Neutrophils Primarily through Formyl Peptide Receptor 1.
Winther M; Holdfeldt A; Gabl M; Wang JM; Forsman H; Dahlgren C
PLoS One; 2016; 11(12):e0167529. PubMed ID: 27907124
[TBL] [Abstract][Full Text] [Related]
29. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation.
Gastardelo TS; Damazo AS; Dalli J; Flower RJ; Perretti M; Oliani SM
Am J Pathol; 2009 Jan; 174(1):177-83. PubMed ID: 19095957
[TBL] [Abstract][Full Text] [Related]
30. Formyl peptide receptor 1 signaling potentiates inflammatory brain injury.
Li Z; Li Y; Han J; Zhu Z; Li M; Liu Q; Wang Y; Shi FD
Sci Transl Med; 2021 Aug; 13(605):. PubMed ID: 34349037
[TBL] [Abstract][Full Text] [Related]
31. Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma.
Itagaki K; Kaczmarek E; Kwon WY; Chen L; Vlková B; Zhang Q; Riça I; Yaffe MB; Campbell Y; Marusich MF; Wang JM; Gong WH; Gao JL; Jung F; Douglas G; Otterbein LE; Hauser CJ
Crit Care Med; 2020 Feb; 48(2):e123-e132. PubMed ID: 31939811
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil infiltration of the colon is independent of the FPR1 yet FPR1 deficient mice show differential susceptibilities to acute versus chronic induced colitis.
Farooq SM; Stadnyk AW
Dig Dis Sci; 2012 Jul; 57(7):1802-12. PubMed ID: 22383080
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
Int Immunopharmacol; 2016 Aug; 37():43-58. PubMed ID: 26382576
[TBL] [Abstract][Full Text] [Related]
34. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
[TBL] [Abstract][Full Text] [Related]
35. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
Kretschmer D; Rautenberg M; Linke D; Peschel A
J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
[TBL] [Abstract][Full Text] [Related]
36. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
[TBL] [Abstract][Full Text] [Related]
37. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.
Winther M; Gabl M; Welin A; Dahlgren C; Forsman H
FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379
[TBL] [Abstract][Full Text] [Related]
38. G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma.
Liu M; Zhao J; Chen K; Bian X; Wang C; Shi Y; Wang JM
Int Immunopharmacol; 2012 Nov; 14(3):283-8. PubMed ID: 22863814
[TBL] [Abstract][Full Text] [Related]
39. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
[TBL] [Abstract][Full Text] [Related]
40. FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis.
Leslie J; Millar BJ; Del Carpio Pons A; Burgoyne RA; Frost JD; Barksby BS; Luli S; Scott J; Simpson AJ; Gauldie J; Murray LA; Finch DK; Carruthers AM; Ferguson J; Sleeman MA; Rider D; Howarth R; Fox C; Oakley F; Fisher AJ; Mann DA; Borthwick LA
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 32102985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
